Gender
Male: 35 (49%)
Female: 36 (51%)
Median age at surgical treatment
48 y (5 - 83 y)
Median follow-up period
7.1 y (0.2 - 17.4 y)
Stage
Stage I: 17 (24%)
Stage II: 21 (30%)
Stage III: 33 (47%)